Impact of exposure to war stress on exacerbations of multiple sclerosis

Annals of Neurology

Volumn 64, Issue 2, 2008, Pages 143-148

  Golan, Daniel ^a   Somer, Eli ^b   Dishon, Sara ^a   Cuzin Disegni, Limor ^a   Miller, Ariel ^a,c  

^a CARMEL MEDICAL CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE EXACERBATION; DISTRESS SYNDROME; EXPERIENCE; FEMALE; HOSTILITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELAPSE; REMISSION; RISK ASSESSMENT; STRESS; VALIDATION STUDY; WAR;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; RISK FACTORS; STRESS, PSYCHOLOGICAL; WAR;

EID: 51549105302     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21409     Document Type: Article

References (30)

1. Charcot JM. Lectures on diseases of the nervous system. London: New Sydenham Society, 1877.
2. Goodin DS, Ebers GC, Johnson KP, et al. The relationship of MS to physical trauma and psychological stress. Neurology 1999;52:1737-1748.
3. Mohr DC, Goodkin DE, Bacchetti P, et al. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000;55:55-61.
4. Ackerman KD, Heyman R, Rabin BS, et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med 2002;64:916-920.
5. Buljevac D, Hop WCJ, Reedeker W, et al. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003;327:646-650.
6. Mohr DC, Hart SL, Julian L, et al. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328:731-736.
7. Brown RF, Tennant CC, Sharrock M, et al. Relationship between stress and relapse in multiple sclerosis: part I. Important features. Mult Scler 2006;12:453-464.
8. Nisipeanu P, Korczyn AD. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993;43:1311-1312.
9. The second Lebanon War 2006. Israel Ministry of Foreign Affairs. Available at: www.mfa.gov.il/MFA/History/Modern+History/Israel+wars. Accessed.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005;58:840-846.
11. Taillefer MV, Roullet E, Cesaro P, Alperovitch A. Validation of self-reported neurological disability in multiple sclerosis. Int J Epidemiol 1994;23:148-154.
12. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
13. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
14. Brown RF, Tennant CC, Dunn SM, Pollard JD. A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005;11:477-484.
15. Steinmetz D, Edelstein H, Dishon S, et al. Hospital-at-home as a solution for the treatment requirements of acute exacerbation in multiple sclerosis. Harefuah 2001;140:603-606.
16. Sibley WA. Risk factors in multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman & Hall, 1997: 141-148.
17. Grant I, Brown GW, Harris T, et al. Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:8-13.
18. Halper J. The psychosocial effect of multiple sclerosis: the impact of relapses. J Neurol Sci 2007;256(suppl 1):S34-S38.
19. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362.
20. Mohr CM, Pelletier D. A temporal framework for understanding the effects of stressful life events in inflammation in patients with multiple sclerosis. Brain Behav Immun 2006;20:27-36.
21. Theoharides TC. Mast cells and stress - a psychoneuroimmunological perspective. J Clin Psychopharmacol 2002;22:103-108.
22. Zappulla JP, Arock M, Mars LT, Liblau RS. Mast cells: new targets for multiple sclerosis therapy? J Neuroimmunol 2002;131:5-20.
23. Theoharides TC, Konstantinidou AD. Corticotropin-releasing hormone and the blood-brain-barrier. Front Biosci 2007;2:1615-1628.
24. Gold SM, Mohr DC, Huitinga I, et al. The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005;26:644-652.
25. Heesen C, Mohr DC, Huitinga I, et al. Stress regulation in multiple sclerosis - current issues and concepts. Mult Scler 2006;12:1-6.
26. DeRijk RH, Eskandari F, Sternberg EM. Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol 2004;151:180-188.
27. Giorelli M, Livrea P, Trojano M. Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from multiple sclerosis patients. J Neuroimmunol 2004;155:143-149.
28. Vroon A, Kavelaars A, Limmroth V, et al. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 2005;174:4400-4406.
29. Stark JL, Avitsur R, Padgett DA, et al. Social stress induces glucocorticoid resistance in macrophages. Am J Physiol Regul Integr Comp Physiol 2001;280:1799-1805.
30. Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 2002;21:531-541.